254 related articles for article (PubMed ID: 37056267)
1. Exosome-guided direct reprogramming of tumor-associated macrophages from protumorigenic to antitumorigenic to fight cancer.
Kim H; Park HJ; Chang HW; Back JH; Lee SJ; Park YE; Kim EH; Hong Y; Kwak G; Kwon IC; Lee JE; Lee YS; Kim SY; Yang Y; Kim SH
Bioact Mater; 2023 Jul; 25():527-540. PubMed ID: 37056267
[TBL] [Abstract][Full Text] [Related]
2. M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages.
Gunassekaran GR; Poongkavithai Vadevoo SM; Baek MC; Lee B
Biomaterials; 2021 Nov; 278():121137. PubMed ID: 34560422
[TBL] [Abstract][Full Text] [Related]
3. Exosome-Guided Phenotypic Switch of M1 to M2 Macrophages for Cutaneous Wound Healing.
Kim H; Wang SY; Kwak G; Yang Y; Kwon IC; Kim SH
Adv Sci (Weinh); 2019 Oct; 6(20):1900513. PubMed ID: 31637157
[TBL] [Abstract][Full Text] [Related]
4. In Situ Reprogramming of Tumor-Associated Macrophages with Internally and Externally Engineered Exosomes.
Zhang L; Lin Y; Li S; Guan X; Jiang X
Angew Chem Int Ed Engl; 2023 Mar; 62(11):e202217089. PubMed ID: 36658634
[TBL] [Abstract][Full Text] [Related]
5. Arginase-1+ Exosomes from Reprogrammed Macrophages Promote Glioblastoma Progression.
Azambuja JH; Ludwig N; Yerneni SS; Braganhol E; Whiteside TL
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32498400
[TBL] [Abstract][Full Text] [Related]
6. Reprogramming tumor-associated macrophages by a dually targeted milk exosome system as a potent monotherapy for cancer.
Chen Y; Gong L; Cao Y; Liu Z; Wang Y; Cheng H; Feng Y; Yao S; Yin Y; Wu Z; Huang Z
J Control Release; 2024 Feb; 366():395-409. PubMed ID: 38184235
[TBL] [Abstract][Full Text] [Related]
7. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
8. The Streptococcus virulence protein PepO triggers anti-tumor immune responses by reprograming tumor-associated macrophages in a mouse triple negative breast cancer model.
Liu B; Huang J; Xiao J; Xu W; Zhang H; Yuan Y; Yin Y; Zhang X
Cell Biosci; 2023 Nov; 13(1):198. PubMed ID: 37925462
[TBL] [Abstract][Full Text] [Related]
9. Slit2 Inhibits Breast Cancer Metastasis by Activating M1-Like Phagocytic and Antifibrotic Macrophages.
Ahirwar DK; Charan M; Mishra S; Verma AK; Shilo K; Ramaswamy B; Ganju RK
Cancer Res; 2021 Oct; 81(20):5255-5267. PubMed ID: 34400395
[TBL] [Abstract][Full Text] [Related]
10. 2-methylpyridine-1-ium-1-sulfonate modifies tumor-derived exosome mediated macrophage polarization: Relevance to the tumor microenvironment.
Rastegari-Pouyani M; Mohammadi-Motlagh HR; Baghaei K; Mansouri K; Hajivalili M; Mostafaie A; Amani D
Int Immunopharmacol; 2022 May; 106():108581. PubMed ID: 35149296
[TBL] [Abstract][Full Text] [Related]
11. Nanomaterials-Involved Tumor-Associated Macrophages' Reprogramming for Antitumor Therapy.
Li SL; Hou HY; Chu X; Zhu YY; Zhang YJ; Duan MD; Liu J; Liu Y
ACS Nano; 2024 Mar; 18(11):7769-7795. PubMed ID: 38420949
[TBL] [Abstract][Full Text] [Related]
12. Targeting tumor-associated macrophages in the tumor microenvironment.
Zhou K; Cheng T; Zhan J; Peng X; Zhang Y; Wen J; Chen X; Ying M
Oncol Lett; 2020 Nov; 20(5):234. PubMed ID: 32968456
[TBL] [Abstract][Full Text] [Related]
13. The role of tumor-associated macrophage in breast cancer biology.
Choi J; Gyamfi J; Jang H; Koo JS
Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
[TBL] [Abstract][Full Text] [Related]
14. Reprogramming of breast tumor-associated macrophages with modulation of arginine metabolism.
Fernando V; Zheng X; Sharma V; Furuta S
bioRxiv; 2023 Aug; ():. PubMed ID: 37662241
[TBL] [Abstract][Full Text] [Related]
15. Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity.
Kamerkar S; Leng C; Burenkova O; Jang SC; McCoy C; Zhang K; Dooley K; Kasera S; Zi T; Sisó S; Dahlberg W; Sia CL; Patel S; Schmidt K; Economides K; Soos T; Burzyn D; Sathyanarayanan S
Sci Adv; 2022 Feb; 8(7):eabj7002. PubMed ID: 35179953
[TBL] [Abstract][Full Text] [Related]
16. Docetaxel-loaded M1 macrophage-derived exosomes for a safe and efficient chemoimmunotherapy of breast cancer.
Zhao Y; Zheng Y; Zhu Y; Li H; Zhu H; Liu T
J Nanobiotechnology; 2022 Aug; 20(1):359. PubMed ID: 35918698
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Reprogramming in Tumor-Associated Macrophages in the Ovarian Tumor Microenvironment.
Kumar S; Mittal S; Gupta P; Singh M; Chaluvally-Raghavan P; Pradeep S
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358644
[TBL] [Abstract][Full Text] [Related]
18. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
Hu S; Ma J; Su C; Chen Y; Shu Y; Qi Z; Zhang B; Shi G; Zhang Y; Zhang Y; Huang A; Kuang Y; Cheng P
Acta Biomater; 2021 Nov; 135():567-581. PubMed ID: 34506976
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Associated Macrophages: Protumoral Macrophages in Inflammatory Tumor Microenvironment.
Malekghasemi S; Majidi J; Baghbanzadeh A; Abdolalizadeh J; Baradaran B; Aghebati-Maleki L
Adv Pharm Bull; 2020 Sep; 10(4):556-565. PubMed ID: 33062602
[TBL] [Abstract][Full Text] [Related]
20. Wnt Signaling in the Phenotype and Function of Tumor-Associated Macrophages.
Tigue ML; Loberg MA; Goettel JA; Weiss WA; Lee E; Weiss VL
Cancer Res; 2023 Jan; 83(1):3-11. PubMed ID: 36214645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
